Immunotherapy in Special Patient Populations and Future Directions

Download this slideset from a live CCO symposium for expert perspective on optimal use of immunotherapy in various patient populations, including those with CNS metastases or poor performance status, along with highlights of emerging data on immunotherapy combination regimens in clinical trials.
person default
Jarushka Naidoo, MB BCH BAO, MHS
Format: Microsoft PowerPoint (.ppt)
File Size: 1.04 MB
Released: November 10, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Regeneron Pharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings